SCHEMBL30968164

SCHEMBL30968164

COC(=O)c1cc(-c2cccc(N)c2OC)nn1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.50
▸ CA1 P00915 2/20 0.50
▸ CA2 P00918 2/20 0.50
▸ CA9 Q16790 2/20 0.50
▸ LMNA P02545 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ PHGDH O43175 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ CFTR P13569 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ HPGD P15428 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ ADORA3 P0DMS8 2/20 0.36
▸ ADORA2A P29274 2/20 0.36
▸ ADORA2B P29275 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ HTR2A P28223 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24950110 1.00 CA12 (0.50) CA12CA1CA2CA9LMNA
SCHEMBL30119787 0.76 PARP1 (0.35) LMNAKDM4EMAPTALDH1A1HPGD
SCHEMBL30051006 0.73 TLR8 (0.35) CA12CA1CA2CA9LMNA
SCHEMBL26983763 0.73 TLR8 (0.35) CA12CA1CA2CA9LMNA
SCHEMBL4298598 0.73 PHGDH (0.59) CA12CA1CA2CA9PHGDH
SCHEMBL30392625 0.72 MAPK1 (0.47) KDM4EMAPTALDH1A1CFTRHSD17B10
SCHEMBL26099039 0.72 MAPK1 (0.47) KDM4EMAPTALDH1A1CFTRHSD17B10
SCHEMBL30050566 0.71 PIM1 (0.33) LMNAKDM4EHTR2AHTR2CPARP1
SCHEMBL26983719 0.71 PIM1 (0.33) LMNAKDM4EHTR2AHTR2CPARP1
SCHEMBL10960030 0.71 CA12 (0.48) CA12CA1CA2CA9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113227071-B Amide-substituted heterocyclic compounds for the treatment of disorders associated with modulation of IL-12, IL-23 and/or IFN-alpha 百时美施贵宝公司 2024-06-25 — — CN disclosed
Send feedback